STOCK TITAN

Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

SEATTLE and VANCOUVER, BC, Oct. 29, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that it will report its third quarter 2020 financial results and provide an update on the cytisinicline development program on Thursday, November 12, 2020 at 4:30PM ET.

To access the webcast, log on to the Investor Relations page of the Achieve website at http://ir.achievelifesciences.com/events-and-webcasts. Alternatively, you may access the live conference call by dialing (877) 472-9809 (U.S. & Canada) or (629) 228-0791 (International) and referencing conference ID 8047128. A webcast replay will be available approximately two hours after the call and will be archived on the website for 90 days. 

Achieve Contact 
Jason Wong 
jwong@bplifescience.com  
(415) 375-3340 ext. 4 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/achieve-life-sciences-to-announce-third-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-november-12-2020-301162254.html

SOURCE Achieve Life Sciences, Inc.

Achieve Life Sciences, Inc.

NASDAQ:ACHV

ACHV Rankings

ACHV Latest News

ACHV Stock Data

162.18M
32.49M
9.28%
26.48%
2.09%
In-Vitro Diagnostic Substance Manufacturing
Manufacturing
Link
United States of America
SEATTLE

About ACHV

achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.